Key terms
About SVA
Sinovac Biotech Ltd. is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. Its product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza, H1N1 influenza, and mumps. The company was founded in 1993 and is headquartered in Beijing, China.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest SVA news
No recent press releases are available for SVA
SVA Financials
Key terms
Ad Feedback
SVA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
SVA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range